Strategic Developments in the Heterozygous Familial Hypercholesterolemia (HeFH) Management Market
The volume of the Heterozygous Familial Hypercholesterolemia HEFH Management Market is on an upward trajectory, driven by innovations in therapy and increased patient awareness. With the market size projected to escalate from 8.16 billion USD in 2024 to an impressive 15.75 billion USD by 2035, the compound annual growth rate (CAGR) of 6.16% underscores a robust growth phase ahead. The...
0 Comentários 0 Compartilhamentos 198 Visualizações 0 Anterior